Historically, the most relevant target has been vascular endothelial growth factor (VEGF), which is abundant in the microenvironment of many solid tumors and binds to its receptor (VEGFR) found on the tumor adjacent vascular endothelium to stimulate angiogenesis. The gene discussed is VEGFA; the disease is neoplasm.